CY1106677T1 - Παρασκευη ν1-(2’-πυριδυλ)-1, 2-προπανοδιαμινο σουλφαμικου οξεος και χρηση αυτου στη συνθεση βιολογικως δραστικων πιπεραζινων - Google Patents
Παρασκευη ν1-(2’-πυριδυλ)-1, 2-προπανοδιαμινο σουλφαμικου οξεος και χρηση αυτου στη συνθεση βιολογικως δραστικων πιπεραζινωνInfo
- Publication number
- CY1106677T1 CY1106677T1 CY20071100843T CY071100843T CY1106677T1 CY 1106677 T1 CY1106677 T1 CY 1106677T1 CY 20071100843 T CY20071100843 T CY 20071100843T CY 071100843 T CY071100843 T CY 071100843T CY 1106677 T1 CY1106677 T1 CY 1106677T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pyridyl
- sulfamic acid
- propanediamino
- synthesis
- preparation
- Prior art date
Links
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 title abstract 2
- 150000004885 piperazines Chemical class 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Μέθοδος κατασκευής Ν1-(2'-πυριδυλ)-1,2-αλκανοδιαμινο σουλφαμικού οξέος του τύπου (II) με αντίδραση μιας ένωσης του τύπου (Ι) με NH2R΄ όπου τα R και R' είναι όπως ορίζονται στη περιγραφή. Η εφεύρεση επίσης περιλαμβάνει την ένωση του τύπου (II) και οπτικά ισομερή αυτής. Η ένωση του τύπου (II) είναι ένα ενδιάμεσο χρήσιμο για κατασκευή χηλικών παραγώγων πιπεραζίνης, τα οποία είναι δραστικά στον 5-ΗΤ1Α υποδοχέα.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36345702P | 2002-03-12 | 2002-03-12 | |
| PCT/US2003/007228 WO2003078396A1 (en) | 2002-03-12 | 2003-03-10 | Preparation of n1-(2’-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106677T1 true CY1106677T1 (el) | 2012-05-23 |
Family
ID=28041771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100843T CY1106677T1 (el) | 2002-03-12 | 2007-06-26 | Παρασκευη ν1-(2’-πυριδυλ)-1, 2-προπανοδιαμινο σουλφαμικου οξεος και χρηση αυτου στη συνθεση βιολογικως δραστικων πιπεραζινων |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6784294B2 (el) |
| EP (2) | EP1483243B1 (el) |
| JP (1) | JP4397693B2 (el) |
| KR (1) | KR20040091720A (el) |
| CN (1) | CN100341854C (el) |
| AR (1) | AR038932A1 (el) |
| AT (2) | ATE360002T1 (el) |
| AU (1) | AU2003220122A1 (el) |
| BR (1) | BR0308315A (el) |
| CA (1) | CA2477886A1 (el) |
| CY (1) | CY1106677T1 (el) |
| DE (2) | DE60330199D1 (el) |
| DK (1) | DK1483243T3 (el) |
| EC (1) | ECSP045291A (el) |
| ES (2) | ES2334836T3 (el) |
| HK (1) | HK1068618A1 (el) |
| IL (1) | IL163829A0 (el) |
| MX (1) | MXPA04008731A (el) |
| NO (1) | NO20044049L (el) |
| NZ (1) | NZ535170A (el) |
| PT (1) | PT1483243E (el) |
| RU (1) | RU2314294C2 (el) |
| SI (1) | SI1483243T1 (el) |
| TW (1) | TWI288642B (el) |
| UA (1) | UA80272C2 (el) |
| WO (1) | WO2003078396A1 (el) |
| ZA (1) | ZA200408213B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060223824A1 (en) * | 2000-11-28 | 2006-10-05 | Wyeth | Serotonergic agents |
| WO2003007956A1 (en) | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| US7361773B2 (en) * | 2002-03-12 | 2008-04-22 | Wyeth | Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| AU2003220122A1 (en) | 2002-03-12 | 2003-09-29 | Wyeth | Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| CA2477906A1 (en) * | 2002-03-12 | 2003-09-25 | Ivo Jirkovsky | Process for making chiral 1,4-disubstituted piperazines |
| US20050215561A1 (en) * | 2004-03-19 | 2005-09-29 | Krishnendu Ghosh | Pharmaceutical dosage forms and compositions |
| US20070099931A1 (en) * | 2004-03-19 | 2007-05-03 | Wyeth | Pharmaceutical dosage forms and compositions |
| PA8626301A1 (es) * | 2004-03-19 | 2006-12-07 | Wyeth Wyeth | Proceso para preparar derivados de n-aril-piperazina |
| TW200700413A (en) * | 2005-03-01 | 2007-01-01 | Wyeth Corp | Crystalline and amorphous 4-cyano-n-{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| CN104072408B (zh) | 2010-03-12 | 2016-09-14 | 日本曹达株式会社 | 含有吡啶环的化合物、及卤代甲基吡啶衍生物以及四唑基肟衍生物的制造方法 |
| EP2602248A1 (en) | 2011-12-05 | 2013-06-12 | University Of Leicester | Novel pyrrole compounds |
| GB201310126D0 (en) * | 2013-06-06 | 2013-07-24 | Univ Leicester | Novel pyrrole derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE81975T1 (de) * | 1984-12-21 | 1992-11-15 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
| JPH01125357A (ja) | 1987-11-06 | 1989-05-17 | Dainippon Pharmaceut Co Ltd | トリペプチドの誘導体 |
| AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
| JP3077047B2 (ja) | 1993-04-16 | 2000-08-14 | 参天製薬株式会社 | 新規ピペラジン誘導体 |
| GB9411099D0 (en) | 1994-06-03 | 1994-07-27 | Wyeth John & Brother Ltd | Piperazine derivatives |
| WO1995033725A1 (en) * | 1994-06-03 | 1995-12-14 | John Wyeth & Brother Limited | Novel processes and intermediates for the preparation of piperazine derivatives |
| GB9514901D0 (en) * | 1995-07-20 | 1995-09-20 | American Home Prod | Piperazine derivatives |
| ATE227268T1 (de) | 1996-04-10 | 2002-11-15 | Merck & Co Inc | Alpha v beta 3 antagonisten |
| AU2003220122A1 (en) | 2002-03-12 | 2003-09-29 | Wyeth | Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| JP4391241B2 (ja) * | 2002-03-12 | 2009-12-24 | ワイス | キラルｎ−アリールピペラジンの合成方法 |
-
2003
- 2003-03-10 AU AU2003220122A patent/AU2003220122A1/en not_active Abandoned
- 2003-03-10 KR KR10-2004-7014252A patent/KR20040091720A/ko active IP Right Grant
- 2003-03-10 DE DE60330199T patent/DE60330199D1/de not_active Expired - Lifetime
- 2003-03-10 ES ES07007755T patent/ES2334836T3/es not_active Expired - Lifetime
- 2003-03-10 MX MXPA04008731A patent/MXPA04008731A/es active IP Right Grant
- 2003-03-10 EP EP03716415A patent/EP1483243B1/en not_active Expired - Lifetime
- 2003-03-10 SI SI200330817T patent/SI1483243T1/sl unknown
- 2003-03-10 RU RU2004130314/04A patent/RU2314294C2/ru not_active IP Right Cessation
- 2003-03-10 JP JP2003576402A patent/JP4397693B2/ja not_active Expired - Fee Related
- 2003-03-10 CA CA002477886A patent/CA2477886A1/en not_active Abandoned
- 2003-03-10 ES ES03716415T patent/ES2283762T3/es not_active Expired - Lifetime
- 2003-03-10 CN CNB038058421A patent/CN100341854C/zh not_active Expired - Fee Related
- 2003-03-10 DK DK03716415T patent/DK1483243T3/da active
- 2003-03-10 WO PCT/US2003/007228 patent/WO2003078396A1/en active IP Right Grant
- 2003-03-10 DE DE60313301T patent/DE60313301T2/de not_active Expired - Lifetime
- 2003-03-10 US US10/385,337 patent/US6784294B2/en not_active Expired - Fee Related
- 2003-03-10 IL IL16382903A patent/IL163829A0/xx unknown
- 2003-03-10 EP EP07007755A patent/EP1801103B1/en not_active Expired - Lifetime
- 2003-03-10 BR BR0308315-2A patent/BR0308315A/pt not_active IP Right Cessation
- 2003-03-10 AT AT03716415T patent/ATE360002T1/de not_active IP Right Cessation
- 2003-03-10 PT PT03716415T patent/PT1483243E/pt unknown
- 2003-03-10 TW TW092105099A patent/TWI288642B/zh not_active IP Right Cessation
- 2003-03-10 NZ NZ535170A patent/NZ535170A/xx unknown
- 2003-03-10 AT AT07007755T patent/ATE449073T1/de not_active IP Right Cessation
- 2003-03-11 AR ARP030100833A patent/AR038932A1/es unknown
- 2003-10-03 UA UA20041008214A patent/UA80272C2/uk unknown
-
2004
- 2004-09-10 EC EC2004005291A patent/ECSP045291A/es unknown
- 2004-09-24 NO NO20044049A patent/NO20044049L/no not_active Application Discontinuation
- 2004-10-11 ZA ZA200408213A patent/ZA200408213B/en unknown
-
2005
- 2005-02-02 HK HK05100856A patent/HK1068618A1/xx not_active IP Right Cessation
-
2007
- 2007-06-26 CY CY20071100843T patent/CY1106677T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106677T1 (el) | Παρασκευη ν1-(2’-πυριδυλ)-1, 2-προπανοδιαμινο σουλφαμικου οξεος και χρηση αυτου στη συνθεση βιολογικως δραστικων πιπεραζινων | |
| CY1105047T1 (el) | Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν | |
| CY1108454T1 (el) | Ενωσεις σπειροπυραζολιου | |
| CY1108456T1 (el) | Ενωσεις βενζιμιδαζολονης | |
| NO20062644L (no) | DPP-IV inhibitorer | |
| DK1295890T3 (da) | Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge | |
| CY1106509T1 (el) | Αμιδοακετονιτριλια κατα των παρασιτων του εντερου | |
| DE60206030D1 (de) | Azofarbstoffe | |
| NO20052907L (no) | Sykloalkylendikarboksylsyreforbindelser som antiinflammatoriske, immunmodulatoriske og antiproliferative midler | |
| BR0308345A (pt) | Processo para derivados de ácido trans-4-amino-1-cicloexanocarboxìlico | |
| NO984195L (no) | Nye benzofuranonderivater og deres fremstilling | |
| BR0213990A (pt) | Derivados de piperazina tendo atividade antagonìstica de sst1 | |
| BRPI0210746B8 (pt) | derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação | |
| CO5590934A2 (es) | Procedimiento de preparacion de derivados de equinocandina | |
| DE69617226T2 (de) | Piperidinderivate. | |
| ATE291568T1 (de) | Herstellung von tamiflu über das zwischenprodukt gallocarbonsäure | |
| TR200400293T4 (tr) | 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi. | |
| ATE275572T1 (de) | Malto-oligosaccharid-derivate und ihre anwendungen | |
| ATE405555T1 (de) | Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält | |
| CY1109434T1 (el) | Νεα διαδικασια και ενδιαμεσα παρασκευης ενωσεων 19-nor-στερο-des-17-αλογονων | |
| CY1105040T1 (el) | Συνεχης μεθοδος δια την παρασκευην παραγωγων σουλφανικης φρουκτοπυραζονης | |
| NO20043047L (no) | Mellomprodukter for LHRH-antagonistsyntese, fremgangsmate for fremstilling derav og fremgangsmate for LHRH-antagonistfremstilling | |
| ATE183502T1 (de) | Octahydro-2-naphthalincarbonsäure-derivate, ihre herstellung und verwendung | |
| SE0101323D0 (sv) | New process | |
| PT1252159E (pt) | Processo para o fabrico de compostos heterociclicos |